[Skip to Content]
[Skip to Content Landing]
Original Investigation
January 28, 2019

Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids

Author Affiliations
  • 1Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School, Baystate, Springfield
  • 2Department of Medicine, Baystate Medical Center, Springfield, Massachusetts
  • 3School of Public Health and Health Sciences, University of Massachusetts, Amherst
  • 4Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois, Chicago
  • 5University of Illinois Hospital & Health Sciences System, Chicago
  • 6Health Services Research and Development Service, Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington
  • 7Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle
  • 8Department of Quantitative Health Science, University of Massachusetts Medical School, Worcester
JAMA Intern Med. 2019;179(3):333-339. doi:10.1001/jamainternmed.2018.5394
Key Points

Question  Among patients hospitalized for an asthma exacerbation and treated with corticosteroids, does the addition of antibiotic therapy result in better outcomes?

Findings  In this cohort study of 19 811 patients hospitalized for an asthma exacerbation treated with corticosteroids, 8788 (44%) received antibiotics during the first 2 days of hospitalization. Compared with patients who were not treated with antibiotics, treated patients had a significantly longer hospital stay, similar rate of treatment failure, and higher risk of antibiotic-related diarrhea.

Meaning  Antibiotic treatment may not be associated with better outcomes and should not be prescribed routinely in adult patients hospitalized for asthma treated with corticosteroids.

Abstract

Importance  Although professional society guidelines discourage use of empirical antibiotics in the treatment of asthma exacerbation, high antibiotic prescribing rates have been recorded in the United States and elsewhere.

Objective  To determine the association of antibiotic treatment with outcomes among patients hospitalized for asthma and treated with corticosteroids.

Design, Setting, and Participants  Retrospective cohort study of data of 19 811 adults hospitalized for asthma exacerbation and treated with systemic corticosteroids in 542 US acute care hospitals from January 1, 2015, through December 31, 2016.

Exposures  Early antibiotic treatment, defined as an treatment with an antibiotic initiated during the first 2 days of hospitalization and prescribed for a minimum of 2 days.

Main Outcomes and Measures  The primary outcome measure was hospital length of stay. Other measures were treatment failure (initiation of mechanical ventilation, transfer to the intensive care unit after hospital day 2, in-hospital mortality, or readmission for asthma) within 30 days of discharge, hospital costs, and antibiotic-related diarrhea. Multivariable adjustment, propensity score matching, propensity weighting, and instrumental variable analysis were used to assess the association of antibiotic treatment with outcomes.

Results  Of the 19 811 patients, the median (interquartile range [IQR]) age was 46 (34-59) years, 14 389 (72.6%) were women, 8771 (44.3%) were white, and Medicare was the primary form of health insurance for 5120 (25.8%). Antibiotics were prescribed for 8788 patients (44.4%). Compared with patients not treated with antibiotics, treated patients were older (median [IQR] age, 48 [36-61] vs 45 [32-57] years), more likely to be white (48.6% vs 40.9%) and smokers (6.6% vs 5.3%), and had a higher number of comorbidities (eg, congestive heart failure, 6.2% vs 5.8%). Those treated with antibiotics had a significantly longer hospital stay (median [IQR], 4 [3-5] vs 3 [2-4] days) and a similar rate of treatment failure (5.4% vs 5.8%). In propensity score–matched analysis, receipt of antibiotics was associated with a 29% longer hospital stay (length of stay ratio, 1.29; 95% CI, 1.27-1.31) and higher cost of hospitalization (median [IQR] cost, $4776 [$3219-$7373] vs $3641 [$2346-$5942]) but with no difference in the risk of treatment failure (propensity score–matched OR, 0.95; 95% CI, 0.82-1.11). Multivariable adjustment, propensity score weighting, and instrumental variable analysis as well as several sensitivity analyses yielded similar results.

Conclusions and Relevance  Antibiotic therapy may be associated with a longer hospital length of stay, higher hospital cost, and similar risk of treatment failure. These results highlight the need to reduce inappropriate antibiotic prescribing among patients hospitalized for asthma.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Conclusions of non-randomised association studies fraught
    Gregory Larkin, MD MSBiost | NE Ohio College of Medicine
    This is a provocative study and certainly begs more questions than answered.
    One can "control for other factors statistically" to an extent. The absence of interaction terms, for example, on age x abx exposure, may temper these results further.
    At bottom, without a proper randomised prospective design, studies like these cannot answer the questions that really matter... Antibiotics may indeed be bootless, but association studies don't generally give us that answer..
    CONFLICT OF INTEREST: None Reported
    ×